Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article atai Life Sciences Makes $50m Investment in Beckley Psytech

atai Life Sciences Makes $50m Investment in Beckley Psytech

  • Post published:January 4, 2024
  • Post category:Analysis/News
Read more about the article Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

  • Post published:December 29, 2023
  • Post category:Analysis/News
Read more about the article BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

  • Post published:December 12, 2023
  • Post category:Analysis/News
Read more about the article Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

  • Post published:November 10, 2023
  • Post category:Analysis/News/Pα+
Read more about the article Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

  • Post published:November 8, 2023
  • Post category:Analysis/News/Pα+
Read more about the article MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

  • Post published:November 8, 2023
  • Post category:Analysis/News
Read more about the article Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

  • Post published:October 31, 2023
  • Post category:Analysis/News
Read more about the article Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

  • Post published:July 28, 2023
  • Post category:Analysis
Read more about the article Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

  • Post published:July 19, 2023
  • Post category:Analysis
Read more about the article An Abridged History of Psychedelic Use and Criminalisation

An Abridged History of Psychedelic Use and Criminalisation

  • Post published:June 27, 2023
  • Post category:Analysis

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More